Novartis Community Statement – CADTH RECOMMENDATION & ACCESS TO ZOLGENSMA
March 30, 2021 As requested, and as part of our ongoing commitment to keep you informed of important milestones regarding Zolgensma® (onasemnogene abeparvovec), I am writing on behalf of…